This finding was confirmed using semiquantitative RT–PCR analysis which showed that CCL2 was expressed in both of the HOSE cell lines tested, while three out of four ovarian cancer cell lines did not express and one out of four had reduced levels of expression (Arnold et al, 2001a). This evidence concerns the gene CCL2 and ovarian cancer.